Time trends and local variation in primary treatment of localized prostate cancer.
By M. Cooperberg, J. Broering, P. Carroll. Journal of Clinical Oncology, 2010
1,042 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/785f31d59f313c1e52018e9d37d9c7695de5e8ba
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Klein
- Christopher M Booth
- I. Tannock
- C. Magi-Galluzzi
- P. Carroll
- M. Cooperberg
- J. Simko
- S. Falzarano
Citations in the corpus
- Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence (2014, background): “Observational data have quantified overtreatment of patients with early-stage prostate cancer and breast cancer (Baxter et al, 2004; Cooperberg et al, 2010).”
- A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. (2014, background): “Despite these recommendations, AS is underutilized, and >90% of men diagnosed with low-risk disease receive immediate treatment with surgery or radiation [3].”